{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:04:49Z","timestamp":1793851489881,"version":"4.6.1"},"reference-count":252,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"publisher","award":["DS640"],"award-info":[{"award-number":["DS640"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The pathogenesis of immune thrombocytopenia (ITP) is complex and involves the dysregulation of immune cells, such as T and B lymphocytes, and several cytokines that promote the production of autoantibodies. In the context of cancer patients, ITP can occur in both primary and secondary forms related to anticancer therapies or the disease itself. Objective: In light of these data, we decided to prepare a literature review that will explain the classification and immunological determinants of the pathogenesis of ITP and present the clinical implications of this condition, especially in patients with cancer. Materials and methods: We reviewed the literature on immunological mechanisms, therapies, and challenges in treating ITP, particularly on cancer patients. Results: The results of the literature review show that ITP in cancer patients can be both primary and secondary, with secondary ITP being more often associated with anticancer therapies such as chemotherapy and immunotherapy. Innovative therapies such as TPO-RA, rituximab, Bruton\u2019s kinase inhibitors, and FcRn receptor inhibitors have shown promising results in treating refractory ITP, especially in patients with chronic disease. Conclusions: ITP is a significant clinical challenge, especially in the context of oncology patients, where both the disease and treatment can worsen thrombocytopenia and increase the risk of bleeding complications. Treatment of oncology patients with ITP requires an individualized approach, and new therapies offer effective tools for managing this condition. Future research into immunological mechanisms may bring further advances in treating ITP and improve outcomes in cancer patients.<\/jats:p>","DOI":"10.3390\/jcm13226738","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T03:53:14Z","timestamp":1731383594000},"page":"6738","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Many Faces of Immune Thrombocytopenia: Mechanisms, Therapies, and Clinical Challenges in Oncological Patients"],"prefix":"10.3390","volume":"13","author":[{"given":"Marek","family":"Kos","sequence":"first","affiliation":[{"name":"Department of Public Health, Medical University of Lublin, 20-400 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8024-7646","authenticated-orcid":false,"given":"Piotr","family":"Tomaka","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, SP ZOZ in \u0141\u0119czna, 21-010 \u0141\u0119czna, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-6659","authenticated-orcid":false,"given":"Paulina","family":"Mertowska","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7121-1396","authenticated-orcid":false,"given":"Sebastian","family":"Mertowski","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0769-5880","authenticated-orcid":false,"given":"Julia","family":"Wojnicka","sequence":"additional","affiliation":[{"name":"Department of Pathobiochemistry and Interdisciplinary Applications of Ion Chromatography, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-5831","authenticated-orcid":false,"given":"Anna","family":"B\u0142a\u017cewicz","sequence":"additional","affiliation":[{"name":"Department of Pathobiochemistry and Interdisciplinary Applications of Ion Chromatography, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-4741","authenticated-orcid":false,"given":"Ewelina","family":"Grywalska","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Bojarski","sequence":"additional","affiliation":[{"name":"General Surgery Department, SP ZOZ in \u0141\u0119czna, 21-010 \u0141\u0119czna, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Schifferli, A., Cavalli, F., Godeau, B., Liebman, H.A., Recher, M., Imbach, P., and K\u00fchne, T. (2021). Understanding Immune Thrombocytopenia: Looking Out of the Box. Front. Med., 8.","DOI":"10.3389\/fmed.2021.613192"},{"key":"ref_2","unstructured":"(2024, September 10). Platelet Disorders\u2014Immune Thrombocytopenia (ITP)|NHLBI, NIH, Available online: https:\/\/www.nhlbi.nih.gov\/health\/immune-thrombocytopenia."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/asheducation.V2012.1.306.3798320","article-title":"Pathogenesis in Immune Thrombocytopenia: New Insights","volume":"2012","author":"Johnsen","year":"2012","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Provan, D., and Semple, J.W. (2022). Recent Advances in the Mechanisms and Treatment of Immune Thrombocytopenia. eBioMedicine, 76.","DOI":"10.1016\/j.ebiom.2022.103820"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MOH.0b013e3282ab98c7","article-title":"The Epidemiology of Immune Thrombocytopenic Purpura","volume":"14","author":"Fogarty","year":"2007","journal-title":"Curr. Opin. Hematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1080\/17474086.2021.1995347","article-title":"Immune Thrombocytopenia","volume":"14","author":"Bussel","year":"2021","journal-title":"Expert Rev. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5114\/polp.2018.74770","article-title":"Primary Immune Thrombocytopaenia in Children\u2014Analysis of Result of Treatment in a Single Centre","volume":"93","author":"Sotel","year":"2018","journal-title":"Pediatr. Pol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Mititelu, A., Onis\u00e2i, M.-C., Ro\u0219ca, A., and Vl\u0103d\u0103reanu, A.M. (2024). Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25042163"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0039-1683416","article-title":"Epidemiology and Clinical Manifestations of Immune Thrombocytopenia","volume":"39","author":"Kohli","year":"2019","journal-title":"Hamostaseologie"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0609.2009.01247.x","article-title":"The Incidence of Idiopathic Thrombocytopenic Purpura among Adults: A Population-Based Study and Literature Review","volume":"83","author":"Abrahamson","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5114\/polp.2021.104829","article-title":"Primary Immune Thrombocytopenia in Children","volume":"96","year":"2021","journal-title":"Pediatr. Pol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.intimp.2019.04.061","article-title":"The Potential Therapeutic Benefit of Resveratrol on Th17\/Treg Imbalance in Immune Thrombocytopenic Purpura","volume":"73","author":"Guo","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1182\/blood-2010-11-321398","article-title":"Platelet Production and Platelet Destruction: Assessing Mechanisms of Treatment Effect in Immune Thrombocytopenia","volume":"117","author":"Barsam","year":"2011","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1097\/HS9.0000000000000574","article-title":"Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments","volume":"5","author":"Audia","year":"2021","journal-title":"Hemasphere"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Andreescu, M. (2023). The Link between Immune Thrombocytopenia and the Cytokine Profile: A Bridge to New Therapeutical Targets. Front. Hematol., 2.","DOI":"10.3389\/frhem.2023.1191178"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Grodzielski, M., Goette, N.P., Glembotsky, A.C., Constanza Baroni Pietto, M., M\u00e9ndez-Huergo, S.P., Pierdominici, M.S., Montero, V.S., Rabinovich, G.A., Molinas, F.C., and Heller, P.G. (2019). Multiple Concomitant Mechanisms Contribute to Low Platelet Count in Patients with Immune Thrombocytopenia. Sci. Rep., 9.","DOI":"10.1038\/s41598-018-38086-1"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"102345","DOI":"10.1016\/j.rpth.2024.102345","article-title":"Immune Attack on Megakaryocytes in Immune Thrombocytopenia","volume":"8","author":"Petito","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_18","unstructured":"Pietras, N.M., Gupta, N., Justiz Vaillant, A.A., and Pearson-Shaver, A.L. (2024). Immune Thrombocytopenia. StatPearls, StatPearls Publishing."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000529662","article-title":"Expert Report on Immune Thrombocytopenia: Current Diagnostics and Treatment\u2014Recommendations from an Expert Group from Austria, Germany, and Switzerland","volume":"46","author":"Matzdorff","year":"2023","journal-title":"Oncol. Res. Treat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejim.2022.11.022","article-title":"Current Approaches for the Diagnosis and Management of Immune Thrombocytopenia","volume":"108","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/CIA.S369574","article-title":"Older Adults and Immune Thrombocytopenia: Considerations for the Clinician","volume":"18","author":"Crickx","year":"2023","journal-title":"Clin. Interv. Aging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.21037\/aob-21-23","article-title":"The Treatment of Immune Thrombocytopenia (ITP)\u2014Focus on Thrombopoietin Receptor Agonists","volume":"6","author":"Kuter","year":"2021","journal-title":"Ann. Blood"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21037\/aob-20-57","article-title":"Immune Thrombocytopenia: The Patient\u2019s Perspective","volume":"6","author":"Kruse","year":"2021","journal-title":"Ann. Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminhematol.2008.12.005","article-title":"Pathobiology of Secondary Immune Thrombocytopenia","volume":"46","author":"Cines","year":"2009","journal-title":"Semin. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2015-07-607903","article-title":"Linkage between the Mechanisms of Thrombocytopenia and Thrombopoiesis","volume":"127","author":"Eto","year":"2016","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.autrev.2017.04.012","article-title":"Pathogenesis of Immune Thrombocytopenia","volume":"16","author":"Audia","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Swinkels, M., Rijkers, M., Voorberg, J., Vidarsson, G., Leebeek, F.W.G., and Jansen, A.J.G. (2018). Emerging Concepts in Immune Thrombocytopenia. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.00880"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ejh.13705","article-title":"T Cell\u2013Mediated Autoimmunity in Immune Thrombocytopenia","volume":"108","author":"Vrbensky","year":"2022","journal-title":"Eur. J. Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/1087057116664029","article-title":"Identification and Validation of Gene Expression Pattern and Signature in Patients with Immune Thrombocytopenia","volume":"22","author":"Ye","year":"2017","journal-title":"SLAS Discov."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kerrigan, S., Moran, N., Kerrigan, S., and Moran, N. (2015). The Non-Thrombotic Role of Platelets in Health and Disease, InTech.","DOI":"10.5772\/58357"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2258988","DOI":"10.1080\/09537104.2023.2258988","article-title":"Anti-GPIb\/IX Autoantibodies Are Associated with Poor Response to Dexamethasone Combined with Rituximab Therapy in Primary Immune Thrombocytopenia Patients","volume":"34","author":"Ding","year":"2023","journal-title":"Platelets"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/jth.12524","article-title":"Association of Autoantibody Specificity and Response to Intravenous Immunoglobulin G Therapy in Immune Thrombocytopenia: A Multicenter Cohort Study","volume":"12","author":"Peng","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1080\/09537104.2022.2053089","article-title":"Association between Megakaryocyte Abnormalities on Bone Marrow Smear and Response to Thrombopoietin Receptor Agonists in Adult Patients with Primary Immune Thrombocytopenia","volume":"33","author":"Walter","year":"2022","journal-title":"Platelets"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.3324\/haematol.2021.279513","article-title":"Diagnosis of Immune Thrombocytopenia, Including Secondary Forms, and Selection of Second-Line Treatment","volume":"107","author":"Bussel","year":"2022","journal-title":"Haematologica"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3390\/hematolrep16020021","article-title":"Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective","volume":"16","author":"Bernardo","year":"2024","journal-title":"Hematol. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12935-019-0779-0","article-title":"Megakaryocytic Dysfunction in Immune Thrombocytopenia Is Linked to Autophagy","volume":"19","author":"Sun","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Jurk, K., and Shiravand, Y. (2021). Platelet Phenotyping and Function Testing in Thrombocytopenia. J. Clin. Med., 10.","DOI":"10.3390\/jcm10051114"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1182\/blood-2017-05-784975","article-title":"Fc-Independent Immune Thrombocytopenia via Mechanomolecular Signaling in Platelets","volume":"131","author":"Quach","year":"2018","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3324\/haematol.11934","article-title":"Autoimmune Thrombocytopenia in Non-Hodgkin\u2019s Lymphomas","volume":"93","author":"Hauswirth","year":"2008","journal-title":"Haematologica"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Fattizzo, B., and Barcellini, W. (2020). Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01435"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Woo, T., Carter, M., Follows, G., and Patten, P.E. (2023). Case Report: Successful Treatment of Refractory Immune Thrombocytopenia in Chronic Lymphocytic Leukaemia with Venetoclax Monotherapy. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1260003"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2169\/internalmedicine.5611-20","article-title":"Treatment of Secondary Immune Thrombocytopenia with Non-Hodgkin Lymphoma: A Case Report and Literature Review","volume":"60","author":"Kurihara","year":"2021","journal-title":"Intern. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Cerreto, M., Fo\u00e0, R., and Natoni, A. (2023). The Role of the Microenvironment and Cell Adhesion Molecules in Chronic Lymphocytic Leukemia. Cancers, 15.","DOI":"10.3390\/cancers15215160"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1182\/blood-2007-09-111492","article-title":"Impact of Immune Thrombocytopenia on the Clinical Course of Chronic Lymphocytic Leukemia","volume":"111","author":"Visco","year":"2008","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1182\/blood.V118.21.2847.2847","article-title":"Immune Thrombocytopenia in Patients with Chronic Lymphocytic Leukemia Is Associated with Stereotyped B-Cell Receptors","volume":"118","author":"Maura","year":"2011","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12967-023-04393-z","article-title":"Fibrosis and Bone Marrow: Understanding Causation and Pathobiology","volume":"21","author":"Ghosh","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Lim, J.H., Kim, Y.K., Min, S.H., Kim, S.W., Lee, Y.H., and Lee, J.M. (2021). Epidemiology and Viral Etiology of Pediatric Immune Thrombocytopenia through Korean Public Health Data Analysis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10071356"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1182\/blood-2008-07-167155","article-title":"Effects of Eradication of Helicobacter Pylori Infection in Patients with Immune Thrombocytopenic Purpura: A Systematic Review","volume":"113","author":"Stasi","year":"2009","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5603\/HCP.2021.0005","article-title":"Secondary Immune Thrombocytopenia after Streptococcus Infection","volume":"12","author":"Korzeniowska","year":"2021","journal-title":"Hematol. Clin. Pract."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000329901","article-title":"Candida Albicans-Induced Chronic Thrombocytopenic Purpura","volume":"126","author":"Alawneh","year":"2011","journal-title":"Acta Haematol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1590\/S0074-02762011000900007","article-title":"Thrombocytopenia in Malaria: Who Cares?","volume":"106","author":"Lacerda","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1002\/ctd2.77","article-title":"Treg Cell Abnormality and Its Potential Treatments in Patients with Primary Immune Thrombocytopenia","volume":"2","author":"Ji","year":"2022","journal-title":"Clin. Transl. Discov."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1182\/bloodadvances.2023009949","article-title":"Deciphering the Genetic Basis of Immune Thrombocytopenia: Current Evidence for Genetic Predisposition in Adult ITP","volume":"7","author":"Georgi","year":"2023","journal-title":"Blood Adv."},{"key":"ref_54","unstructured":"(2024, October 11). ITP and Cancer Risk: More Data and Some Questions\u2014Chronic Immune Thrombocytopenia: Meeting the Challenge. Available online: https:\/\/www.medpagetoday.com\/resource-centers\/chronic-immune-thrombocytopenia-meeting-challenge\/itp-and-cancer-risk-more-data-and-some-questions\/3163."},{"key":"ref_55","first-page":"282","article-title":"Managing Thrombocytopenia Associated with Cancer Chemotherapy","volume":"29","author":"Kuter","year":"2015","journal-title":"Oncology"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Tan, J.H., Ahmad Azahari, A.H.S., Ali, A., and Ismail, N.A.S. (2023). Scoping Review on Epigenetic Mechanisms in Primary Immune Thrombocytopenia. Genes, 14.","DOI":"10.3390\/genes14030555"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA Methylation and Its Basic Function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1002\/ctd2.279","article-title":"Role of DNA Methylation in Cancer Development and Its Clinical Applications","volume":"4","author":"Sonar","year":"2024","journal-title":"Clin. Transl. Discov."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-43624-1_7","article-title":"The Role of DNA Methylation in Cancer","volume":"945","author":"Lakshminarasimhan","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-020-01197-3","article-title":"Epigenetic Regulation in Human Cancer: The Potential Role of Epi-Drug in Cancer Therapy","volume":"19","author":"Lu","year":"2020","journal-title":"Mol. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","article-title":"Cancer Epigenetics: From Laboratory Studies and Clinical Trials to Precision Medicine","volume":"10","author":"Yu","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1399-0004.2011.01809.x","article-title":"Epigenetic Modifications in Cancer","volume":"81","author":"Kanwal","year":"2012","journal-title":"Clin. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.biochi.2012.05.007","article-title":"Epigenomics of Cancer\u2014Emerging New Concepts","volume":"94","author":"Hassler","year":"2012","journal-title":"Biochimie"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.36401\/JIPO-20-18","article-title":"Cancer Epigenomics and Beyond: Advancing the Precision Oncology Paradigm","volume":"3","author":"Lee","year":"2020","journal-title":"J. Immunother. Precis. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.gendis.2018.06.003","article-title":"Epigenetic Mechanisms as a New Approach in Cancer Treatment: An Updated Review","volume":"5","author":"Fardi","year":"2018","journal-title":"Genes Dis."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Miranda-Gon\u00e7alves, V., Lameirinhas, A., Henrique, R., and Jer\u00f3nimo, C. (2018). Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets. Front. Genet., 9.","DOI":"10.3389\/fgene.2018.00427"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"10760296221093595","DOI":"10.1177\/10760296221093595","article-title":"The Extensive Regulation of MicroRNA in Immune Thrombocytopenia","volume":"28","author":"Zhao","year":"2022","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Testa, U., Pelosi, E., Castelli, G., and Labbaye, C. (2017). miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor Development. Non-Coding RNA, 3.","DOI":"10.3390\/ncrna3030022"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/gm516","article-title":"MicroRNAs and the Cancer Phenotype: Profiling, Signatures and Clinical Implications","volume":"5","author":"Stahlhut","year":"2013","journal-title":"Genome Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12935-019-0886-y","article-title":"Protective Potential of miR-146a-5p and Its Underlying Molecular Mechanism in Diverse Cancers: A Comprehensive Meta-Analysis and Bioinformatics Analysis","volume":"19","author":"Li","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1756-8722-5-13","article-title":"The Emerging Role of MIR-146A in the Control of Hematopoiesis, Immune Function and Cancer","volume":"5","author":"Labbaye","year":"2012","journal-title":"J. Hematol. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13046-018-0679-5","article-title":"The miR-181 Family Promotes Cell Cycle by Targeting CTDSPL, a Phosphatase-like Tumor Suppressor in Uveal Melanoma","volume":"37","author":"Zhang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00277-016-2703-1","article-title":"Bone Marrow Niche in Immune Thrombocytopenia: A Focus on Megakaryopoiesis","volume":"95","author":"Khodadi","year":"2016","journal-title":"Ann. Hematol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12185-013-1370-4","article-title":"Pathophysiology and Management of Primary Immune Thrombocytopenia","volume":"98","author":"Kashiwagi","year":"2013","journal-title":"Int. J. Hematol."},{"key":"ref_75","unstructured":"(2024, September 11). Immune Thrombocytopenia (ITP)\u2014Diagnosis and Treatment\u2014Mayo Clinic. Available online: https:\/\/www.mayoclinic.org\/diseases-conditions\/idiopathic-thrombocytopenic-purpura\/diagnosis-treatment\/drc-20352330."},{"key":"ref_76","unstructured":"(2024, September 11). Immune Thrombocytopenia (ITP)\u2014Symptoms and Causes. Available online: https:\/\/www.mayoclinic.org\/diseases-conditions\/idiopathic-thrombocytopenic-purpura\/symptoms-causes\/syc-20352325."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s12288-011-0124-9","article-title":"Thrombocytopenia in HIV-Infected Patients","volume":"28","author":"Nascimento","year":"2012","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2200836","DOI":"10.1080\/09537104.2023.2200836","article-title":"Clinical Features and Treatment Effect of HIV-Associated Immune Thrombocytopenia\u2014Single Center Ten-Years Data Summary","volume":"34","author":"Tan","year":"2023","journal-title":"Platelets"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e01643","DOI":"10.1016\/j.idcr.2022.e01643","article-title":"Severe Thrombocytopenia in Primary EBV- Infection with No Signs of Infectious Mononucleosis. A Case Report","volume":"30","author":"Kotsev","year":"2022","journal-title":"IDCases"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e2023023","DOI":"10.4084\/MJHID.2023.023","article-title":"Hematological Abnormalities Beyond Lymphocytosis During Infectious Mononucleosis: Epstein-Barr Virus-Induced Thrombocytopenia","volume":"15","author":"Alende","year":"2023","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/17474086.2022.2029699","article-title":"COVID-19 Associated with Immune Thrombocytopenia: A Systematic Review and Meta-Analysis","volume":"15","author":"Alharbi","year":"2022","journal-title":"Expert Rev. Hematol."},{"key":"ref_82","first-page":"e39342","article-title":"Immune Thrombocytopenic Purpura Following COVID-19 Infection: A Case Report and Literature Review","volume":"15","author":"Nguyen","year":"2023","journal-title":"Cureus"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Shinno, K., Banno, Y., and Kamimaki, I. (2023). Severe Immune Thrombocytopenia That Developed Immediately after COVID-19 in a School-Aged Patient: A Case Report. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1120093"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e7872","DOI":"10.1002\/ccr3.7872","article-title":"Relapse of Immune Thrombocytopenia after Receiving AstraZeneca Coronavirus Disease-2019 Vaccine: A Case Report","volume":"11","author":"Seyedi","year":"2023","journal-title":"Clin. Case Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.amjms.2022.05.017","article-title":"SARS-Cov-2 Infection in Cancer Patients, Susceptibility, Outcome and Care","volume":"364","author":"Alaeddini","year":"2022","journal-title":"Am. J. Med. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood.2021013411","article-title":"SARS-CoV-2 Vaccination and ITP in Patients with de Novo or Preexisting ITP","volume":"139","author":"Lee","year":"2022","journal-title":"Blood"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3748\/wjg.v20.i3.714","article-title":"Helicobacter Pylori-Associated Immune Thrombocytopenia: Clinical Features and Pathogenic Mechanisms","volume":"20","author":"Kuwana","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3934\/microbiol.2021018","article-title":"Helicobacter Pylori Induced Immune Thrombocytopenic Purpura and Perspective Role of Helicobacter Pylori Eradication Therapy for Treating Immune Thrombocytopenic Purpura","volume":"7","author":"Ihtesham","year":"2021","journal-title":"AIMS Microbiol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Lee, A., Hong, J., Chung, H., Koh, Y., Cho, S.-J., Byun, J.M., Kim, S.G., and Kim, I. (2020). Helicobacter Pylori Eradication Affects Platelet Count Recovery in Immune Thrombocytopenia. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-66460-5"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"105923","DOI":"10.1016\/j.isci.2022.105923","article-title":"Streptococcus Pneumoniae Promotes Lung Cancer Development and Progression","volume":"26","author":"Li","year":"2023","journal-title":"iScience"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Nates, J.L., and Price, K.J. (2020). Pneumonia in the Cancer Patient. Oncologic Critical Care, Springer International Publishing.","DOI":"10.1007\/978-3-319-74588-6"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1097\/MPH.0000000000001338","article-title":"Hematologic Manifestations of Nutritional Deficiencies: Early Recognition Is Essential to Prevent Serious Complications","volume":"41","author":"Yu","year":"2019","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_93","first-page":"e44162","article-title":"Vitamin B12 Deficiency, a Rare Cause of Isolated Thrombocytopenia in Adults","volume":"15","author":"Khan","year":"2023","journal-title":"Cureus"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1007\/s12325-020-01453-4","article-title":"Platelet Dysfunction Diseases and Conditions: Clinical Implications and Considerations","volume":"37","author":"Kaye","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_95","unstructured":"(2024, September 11). Immune Thrombocytopenia (ITP)\u2014Hematology and Oncology. Available online: https:\/\/www.merckmanuals.com\/professional\/hematology-and-oncology\/thrombocytopenia-and-platelet-dysfunction\/immune-thrombocytopenia-itp."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-023-01401-z","article-title":"How We Treat Primary Immune Thrombocytopenia in Adults","volume":"16","author":"Liu","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"ref_97","first-page":"e40199","article-title":"Immune Thrombocytopenia Secondary to COVID-19 in a Vitamin B12-Deficient Patient: A Diagnostic Dilemma and Therapeutic Challenge","volume":"15","author":"Bijaya","year":"2023","journal-title":"Cureus"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"102717","DOI":"10.1016\/j.transci.2019.102717","article-title":"Vitamin B12 Deficiency and Metabolism-Mediated Thrombotic Microangiopathy (MM-TMA)","volume":"59","author":"Sabry","year":"2020","journal-title":"Transfus. Apher. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1182\/blood.V106.11.4016.4016","article-title":"Bone Marrow Effects of High Dose Folic Acid Therapy in Chronic Idiopathic Thrombocytopenic Purpura","volume":"106","author":"Schulz","year":"2005","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00277-019-03666-2","article-title":"Patterns and Utility of Vitamin B12 and Folate Testing in Patients with Isolated Thrombocytopenia","volume":"98","author":"DeLoughery","year":"2019","journal-title":"Ann. Hematol."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Peterson, C.T., Rodionov, D.A., Osterman, A.L., and Peterson, S.N. (2020). B Vitamins and Their Role in Immune Regulation and Cancer. Nutrients, 12.","DOI":"10.3390\/nu12113380"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s13668-018-0237-y","article-title":"Folate and Its Impact on Cancer Risk","volume":"7","author":"Pieroth","year":"2018","journal-title":"Curr. Nutr. Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"104061","DOI":"10.1016\/j.critrevonc.2023.104061","article-title":"Folate, Folic Acid, and Chemotherapy-Induced Toxicities: A Systematic Literature Review","volume":"188","author":"Zwart","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.3748\/wjg.v21.i13.4101","article-title":"Lower Folate Levels in Gastric Cancer: Is It a Cause or a Result?","volume":"21","author":"Alkan","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"11313","DOI":"10.3748\/wjg.v20.i32.11313","article-title":"Lower Serum Folate Is Associated with Development and Invasiveness of Gastric Cancer","volume":"20","author":"Lee","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3731S","DOI":"10.1093\/jn\/133.11.3731S","article-title":"Role of Folate in Colon Cancer Development and Progression","volume":"133","author":"Kim","year":"2003","journal-title":"J. Nutr."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/ijc.30809","article-title":"Low Vitamin B12 Increases Risk of Gastric Cancer: A Prospective Study of One-Carbon Metabolism Nutrients and Risk of Upper Gastrointestinal Tract Cancer","volume":"141","author":"Miranti","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"689","DOI":"10.21873\/anticanres.16207","article-title":"Clinical Course of Vitamin B12 Deficiency and Associated Risk Factors in Patients After Total Gastrectomy for Gastric Cancer","volume":"43","author":"Aoyama","year":"2023","journal-title":"Anticancer Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ajh.10368","article-title":"Two Patients with Heparin-Induced Thrombocytopenia Followed by Idiopathic (Immune) Thrombocytopenic Purpura: Case Report","volume":"73","author":"Waheed","year":"2003","journal-title":"Am. J. Hematol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000435806","article-title":"Drug-Immune Thrombocytopenia with Thrombosis versus Heparin-Induced Thrombocytopenia: A Critical Clinical Controversy","volume":"5","year":"2015","journal-title":"Case Rep. Nephrol. Dial."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1053\/j.seminhematol.2013.03.020","article-title":"Immune Thrombocytopenia Patients Requiring Anticoagulation\u2014Maneuvering Between Scylla and Charybdis","volume":"50","author":"Matzdorff","year":"2013","journal-title":"Semin. Hematol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"151479","DOI":"10.1016\/j.semnephrol.2023.151479","article-title":"Immunologic Effects of Heparin Associated with Hemodialysis: Focus on Heparin-Induced Thrombocytopenia","volume":"43","author":"Warkentin","year":"2023","journal-title":"Semin. Nephrol."},{"key":"ref_113","first-page":"359","article-title":"A Large-Scale Retrospective Study on Thrombocytopenia Associated with Beta-Lactam Antibiotics","volume":"2022","author":"Chen","year":"2023","journal-title":"AMIA Annu. Symp. Proc."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.artd.2020.03.006","article-title":"Drug-Induced Thrombocytopenia Secondary to Commonly Used Antibiotics in Total Joint Arthroplasty","volume":"6","author":"Wu","year":"2020","journal-title":"Arthroplast. Today"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/trf.16295","article-title":"Immune Thrombocytopenia Induced by Beta-Lactam Antibiotics: Cross-Reactions of Responsible Antibodies with Other Beta-Lactam Drugs","volume":"61","author":"Slaught","year":"2021","journal-title":"Transfusion"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa065066","article-title":"Vancomycin-Induced Immune Thrombocytopenia","volume":"356","author":"Drygalski","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_117","first-page":"e7940","article-title":"A Case of Vancomycin-Induced Immune Thrombocytopenia","volume":"12","author":"MacDougall","year":"2020","journal-title":"Cureus"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.2169\/internalmedicine.55.6902","article-title":"Vancomycin-Induced Immune Thrombocytopenia Proven by the Detection of Vancomycin-Dependent Anti-Platelet Antibody with Flow Cytometry","volume":"55","author":"Yamanouchi","year":"2016","journal-title":"Intern. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/0970-2113.92380","article-title":"Thrombocytopenia Due to Rifampicin","volume":"29","author":"Dixit","year":"2012","journal-title":"Lung India"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/0253-7613.68432","article-title":"Rifampicin-Induced Thrombocytopenia","volume":"42","author":"Verma","year":"2010","journal-title":"Indian J. Pharmacol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40268-017-0224-6","article-title":"The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data","volume":"18","author":"Buoli","year":"2018","journal-title":"Drugs R D"},{"key":"ref_122","first-page":"e57030","article-title":"Valproic Acid-Induced Thrombocytopenia in Treatment-Resistant GABRB3 Genetic Epilepsy: A Case Report","volume":"16","author":"Schuler","year":"2024","journal-title":"Cureus"},{"key":"ref_123","first-page":"OD12","article-title":"Carbamazepine Induced Thrombocytopenia","volume":"11","author":"Kumar","year":"2017","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"103228","DOI":"10.1016\/j.transci.2021.103228","article-title":"Carbamazepine-Induced Immune Thrombocytopenia Confirmed by Modified MASPAT Test","volume":"60","author":"Chen","year":"2021","journal-title":"Transfus. Apher. Sci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/09537104.2011.633179","article-title":"Drug-Induced Immune Thrombocytopenia: A Descriptive Survey in the French PharmacoVigilance Database","volume":"23","author":"Moulis","year":"2012","journal-title":"Platelets"},{"key":"ref_126","first-page":"41","article-title":"A Rare Case of Immune Thrombocytopenia After Unintentional Acetaminophen Overdose","volume":"4","author":"Larson","year":"2022","journal-title":"Grad. Med. Educ. Res. J."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13256-019-2097-5","article-title":"Diclofenac-Induced Thrombotic Thrombocytopenic Purpura with Concomitant Complement Dysregulation: A Case Report and Review of the Literature","volume":"13","author":"Lara","year":"2019","journal-title":"J. Med. Case Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3324\/haematol.2021.279512","article-title":"Treatment of Chemotherapy-Induced Thrombocytopenia in Patients with Non-Hematologic Malignancies","volume":"107","author":"Kuter","year":"2022","journal-title":"Haematologica"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ekir.2021.03.001","article-title":"Treatment of Gemcitabine-Induced Thrombotic Microangiopathy Followed by Gemcitabine Rechallenge with Eculizumab","volume":"6","author":"Efe","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_130","first-page":"e23525","article-title":"Mitomycin-Induced Thrombotic Thrombocytopenic Purpura Treated Successfully with Plasmapheresis and Steroid: A Case Report","volume":"14","author":"Khaja","year":"2022","journal-title":"Cureus"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clcc.2011.03.012","article-title":"Mitomycin\u2013C-Induced Thrombotic Thrombocytopenic Purpura\/Hemolytic Uremic Syndrome: Cumulative Toxicity of an Old Drug in a New Era","volume":"10","author":"Podoltsev","year":"2011","journal-title":"Clin. Color. Cancer"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/j.2055-2335.2013.tb00259.x","article-title":"Mitomycin-C-Induced Thrombotic Thrombocytopenic Purpura","volume":"43","author":"Crosara","year":"2013","journal-title":"J. Pharm. Pract. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.12998\/wjcc.v6.i15.1024","article-title":"Gastric Cancer with Severe Immune Thrombocytopenia: A Case Report","volume":"6","author":"Zhao","year":"2018","journal-title":"World J. Clin. Cases"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1159\/000511067","article-title":"Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the Literature","volume":"13","author":"Cockrell","year":"2020","journal-title":"Case Rep. Oncol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.critrevonc.2011.02.004","article-title":"Paraneoplastic Autoimmune Thrombocytopenia in Solid Tumors","volume":"81","author":"Krauth","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4081\/oncol.2019.413","article-title":"Thrombocytopenia in Solid Tumors: Prognostic Significance","volume":"13","author":"Ghanavat","year":"2019","journal-title":"Oncol. Rev."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/s41416-024-02630-w","article-title":"Risk and Adverse Clinical Outcomes of Thrombocytopenia among Patients with Solid Tumors\u2014A Danish Population-Based Cohort Study","volume":"130","author":"Adelborg","year":"2024","journal-title":"Br. J. Cancer"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1182\/blood-2023-190667","article-title":"Immunotherapy-Associated Immune Thrombocytopenia: Treatment Paradigms","volume":"142","author":"Grinsztejn","year":"2023","journal-title":"Blood"},{"key":"ref_139","first-page":"1","article-title":"Primary Immune Thrombocytopenia and Breast Cancer: Case Report and Review of Literature","volume":"2","author":"Vyas","year":"2017","journal-title":"J. Hematol. Blood Disord."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"101806","DOI":"10.1016\/j.canep.2020.101806","article-title":"Cancer Risk in Patients with Primary Immune Thrombocytopenia\u2014A Swedish Nationwide Register Study","volume":"69","author":"Ekstrand","year":"2020","journal-title":"Cancer Epidemiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.3332\/ecancer.2020.1012","article-title":"Multiple Myeloma with Concurrent Immune Thrombocytopenic Purpura","volume":"14","author":"Sarfraz","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1016\/j.clml.2024.05.020","article-title":"Association of Thrombocytopenia with Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated with Novel Therapies","volume":"24","author":"Charalampous","year":"2024","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"A5","DOI":"10.1186\/1756-8722-2-S1-A5","article-title":"Update on Chronic Immune Thrombocytopenic Purpura (ITP)","volume":"2","author":"McMillan","year":"2009","journal-title":"J. Hematol. Oncol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP Syndrome: Pathogenic and Clinical Diversity","volume":"113","author":"Cines","year":"2009","journal-title":"Blood"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00262-021-03068-2","article-title":"Immune Checkpoint Inhibitor-Related Thrombocytopenia: Incidence, Risk Factors and Effect on Survival","volume":"71","author":"Haddad","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ctrc.2016.02.009","article-title":"Immune Thrombocytopenia Exacerbated by Nivolumab in a Patient with Non-Small-Cell Lung Cancer","volume":"6","author":"Bagley","year":"2016","journal-title":"Cancer Treat. Commun."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Liu, X., Liang, X., Liang, J., Li, Y., and Wang, J. (2020). Immune Thrombocytopenia Induced by Immune Checkpoint Inhibitors in Solid Cancer: Case Report and Literature Review. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.530478"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Xie, W., Hu, N., and Cao, L. (2021). Immune Thrombocytopenia Induced by Immune Checkpoint Inhibitrs in Lung Cancer: Case Report and Literature Review. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.790051"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijscr.2019.08.027","article-title":"Combined Subtotal Gastrectomy and Splenectomy after Partial Splenic Embolization for a Patient with Gastric Cancer and Immune Thrombocytopenic Purpura: A Case Report","volume":"62","author":"Kaneko","year":"2019","journal-title":"Int. J. Surg. Case Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"S943","DOI":"10.14309\/01.ajg.0000709344.35684.95","article-title":"S1824 A Rare Case of Immune Thrombocytopenic Purpura as Initial Presentation of Right-Sided Colon Cancer","volume":"115","author":"Zahra","year":"2020","journal-title":"Off. J. Am. Coll. Gastroenterol. ACG"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clcc.2020.10.004","article-title":"Occurrence and Management of Thrombocytopenia in Metastatic Colorectal Cancer Patients Receiving Chemotherapy: Secondary Analysis of Data from Prospective Clinical Trials","volume":"20","author":"Kilpatrick","year":"2021","journal-title":"Clin. Color. Cancer"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1308\/003588413X13511609957498","article-title":"Management of Colorectal Cancer Liver Metastasis in a Patient with Immune Thrombocytopaenia","volume":"95","author":"Yacob","year":"2013","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/ccr3.1210","article-title":"Acute Drop of Platelets in Metastatic Colon Cancer","volume":"5","author":"Ahmed","year":"2017","journal-title":"Clin. Case Rep."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4143\/crt.2014.052","article-title":"Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report","volume":"47","author":"Woo","year":"2015","journal-title":"Cancer Res. Treat."},{"key":"ref_155","first-page":"4314797","article-title":"Acute Immune-Mediated Thrombocytopenia Due to Oxaliplatin and Irinotecan Therapy","volume":"2019","author":"Tam","year":"2019","journal-title":"Case Rep. Oncol. Med."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.3748\/wjg.v21.i25.7895","article-title":"Thrombocytopenia for Prediction of Hepatocellular Carcinoma Recurrence: Systematic Review and Meta-Analysis","volume":"21","author":"Pang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/hematology.2022000408","article-title":"Thrombocytopenia and Liver Disease: Pathophysiology and Periprocedural Management","volume":"2022","author":"Lim","year":"2022","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/curroncol29030124","article-title":"Low Platelet Count Predicts Reduced Survival in Potentially Resectable Hepatocellular Carcinoma","volume":"29","author":"Schrecker","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_159","unstructured":"(2024, September 11). Liver Cancer May Unexpectedly Be Influenced by Platelets|Center for Cancer Research, Available online: https:\/\/ccr.cancer.gov\/news\/article\/liver-cancer-may-unexpectedly-be-influenced-by-platelets."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12957-021-02160-2","article-title":"The Impact of Thrombocytopenia on Prognosis of HBV-Related Small Hepatocellular Carcinoma: A Propensity Score Matching Analysis","volume":"19","author":"Peng","year":"2021","journal-title":"World J. Surg. Oncol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jons.2016.04.006","article-title":"Endometrial Carcinoma and Paraneoplastic Immune Thrombocytopenia","volume":"2","author":"Kodaz","year":"2016","journal-title":"J. Oncol. Sci."},{"key":"ref_162","first-page":"539","article-title":"Idiopathic Thrombocytopenic Purpura and Ovarian Cancer","volume":"24","author":"Chehal","year":"2003","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/jog.12731","article-title":"Immune Thrombocytopenia Associated with Solid Cancer","volume":"41","author":"Shimada","year":"2015","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1200\/jco.2005.23.16_suppl.5049","article-title":"Relationship between Thrombocytopenia and Survival of Patients with Epithelial Ovarian Cancer (EOC) Who Received Paclitaxel and Carboplatin Chemotherapy","volume":"23","author":"Nagao","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_165","first-page":"21","article-title":"Severe Thrombocytopenia Cured After Ovarian Tumours Surgical Removal","volume":"5","author":"Catoiu","year":"2021","journal-title":"Acta Sci. Med. Sci."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1671::AID-CNCR22>3.0.CO;2-A","article-title":"Ifosfamide, Paclitaxel, and Cisplatin for Patients with Advanced Transitional Cell Carcinoma of the Urothelial Tract: Final Report of a Phase II Trial Evaluating Two Dosing Schedules","volume":"88","author":"Bajorin","year":"2000","journal-title":"Cancer"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5152\/tjh.2011.35","article-title":"Paclitaxel Therapy and Immune Thrombocytopenic Purpura: Coincidence or Association?","volume":"28","author":"Arslan","year":"2011","journal-title":"Turk. J. Hematol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10147-010-0149-3","article-title":"Successful Surgical Treatment and Chemotherapy for Ovarian Cancer in a Patient with Idiopathic Thrombocytopenic Purpura","volume":"16","author":"Wakana","year":"2011","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3923\/ijcr.2006.159.160","article-title":"Severe Immune Thrombocytopenia in a Case of Cervical Carcinoma","volume":"2","author":"Nandigam","year":"2006","journal-title":"Int. J. Cancer Res."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Liu, N., Lv, D., Schneider, R.R., Yang, H., Zhang, M., Liu, Y., and Sun, M. (2023). Intracavitary Cardiac Metastasis of Cervical Squamous Cell Carcinoma with Immune Thrombocytopenia: A Rare Case Report. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1239606"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.7314\/APJCP.2015.16.12.4905","article-title":"Relations of Platelet Indices with Endometrial Hyperplasia and Endometrial Cancer","volume":"16","author":"Karateke","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_172","first-page":"359","article-title":"Pre-Treatment Thrombocytosis Predicts Prognosis of Endometrial Cancer: A Meta-Analysis of 11 Studies","volume":"19","author":"Ye","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1182\/blood.V126.23.4646.4646","article-title":"The Incidence and Characterization of ITP in Prostate Cancer","volume":"126","author":"Vontela","year":"2015","journal-title":"Blood"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.21037\/tlcr-22-745","article-title":"Immune Thrombocytopenia in a Small Cell Lung Cancer Patient Treated with Atezolizumab: A Case Report","volume":"11","author":"Qiu","year":"2022","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.rmedx.2007.06.001","article-title":"Chemotherapy for Small Cell Lung Cancer in a Patient with Idiopathic Thrombocytopenic Purpura","volume":"3","author":"Ogawa","year":"2007","journal-title":"Respir. Med. Extra"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4993\/acrt.27.8","article-title":"Thrombocytopenia Due to Bone Marrow Metastasis of Small Cell Lung Cancer That Was Stabilized by Chemotherapy","volume":"27","author":"Ohta","year":"2019","journal-title":"Ann. Cancer Res. Ther."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000431213","article-title":"Metastatic Breast Cancer with Extensive Osseous Metastasis Presenting with Symptomatic Immune Thrombocytopenic Purpura and Anemia: A Case Report and Review of the Literature","volume":"8","author":"Niu","year":"2015","journal-title":"Case Rep. Oncol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3892\/ol.2023.13918","article-title":"Clinical Features and Treatment of Bone Marrow Metastasis","volume":"26","author":"Yang","year":"2023","journal-title":"Oncol. Lett."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.achaem.2017.05.001","article-title":"Metastasis of Solid Tumors into Bone Marrow\u2014Single Center Experience","volume":"48","author":"Helbig","year":"2017","journal-title":"Acta Haematol. Pol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.3747\/co.24.3592","article-title":"A Case of Metastatic Prostate Cancer and Immune Thrombocytopenia","volume":"24","author":"Betsch","year":"2017","journal-title":"Curr. Oncol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/annonc\/mdp305","article-title":"Immune Thrombocytopenic Purpura (ITP) and Breast Cancer. Does Adjuvant Therapy for Breast Cancer Improve Platelet Counts in ITP?","volume":"20","author":"Khasraw","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1200\/jco.2006.24.18_suppl.4542","article-title":"Prospective Trial of Ifosfamide, Paclitaxel, and Cisplatin (ITP) in Patients with Advanced Non-Transitional Cell (Non-TCC) Carcinomas of the Urothelial Tract","volume":"24","author":"Galsky","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12672-023-00616-3","article-title":"Chemotherapy-Induced Thrombocytopenia: Literature Review","volume":"14","author":"Gao","year":"2023","journal-title":"Discov. Oncol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"v113","DOI":"10.1093\/annonc\/mdj964","article-title":"Gemcitabine in the Treatment of Advanced Transitional Cell Carcinoma of the Urothelium","volume":"17","author":"Bellmunt","year":"2006","journal-title":"Ann. Oncol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ijscr.2013.05.019","article-title":"Successful Perioperative Management of a Patient with Idiopathic Thrombocytopenic Purpura Undergoing Emergent Appendectomy: Report of a Case","volume":"4","author":"Toyomasu","year":"2013","journal-title":"Int. J. Surg. Case Rep."},{"key":"ref_186","unstructured":"George, J.N., and Buchanan, G.R. (2024, September 11). Surgery in the Patient with ITP. Available online: https:\/\/itpsupport.org.uk\/wp-content\/uploads\/2024\/04\/11.-Surgery-in-the-Patient-with-ITP.pages.pdf."},{"key":"ref_187","unstructured":"(2024, September 11). Immune Thrombocytopenia Surgical Management. Available online: https:\/\/www.rarediseaseadvisor.com\/hcp-resource\/immune-thrombocytopenia-surgical-management\/."},{"key":"ref_188","unstructured":"(2024, September 11). Immune Thrombocytopenia (ITP) Treatment & Management: Approach Considerations, Thrombopoietin Receptor Agonists, Treatment in Children. Available online: https:\/\/emedicine.medscape.com\/article\/202158-treatment?form=fpf."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/OAEM.S331675","article-title":"Assessment and Management of Immune Thrombocytopenia (ITP) in the Emergency Department: Current Perspectives","volume":"14","author":"Zitek","year":"2022","journal-title":"Open Access Emerg. Med."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"e36936","DOI":"10.1097\/MD.0000000000036936","article-title":"Recent Advances in the Management of Immune Thrombocytopenic Purpura (ITP): A Comprehensive Review","volume":"103","author":"Madkhali","year":"2024","journal-title":"Medicine"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MOH.0000000000000072","article-title":"The Coagulopathy of Cancer","volume":"21","author":"Falanga","year":"2014","journal-title":"Curr. Opin. Hematol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"100283","DOI":"10.1016\/j.ahjo.2023.100283","article-title":"Bleeding and Thrombotic Events in Bevacizumab-Treated Patients with Colorectal Cancer on Novel Oral Anticoagulants and Antiplatelet Medications","volume":"27","author":"Rho","year":"2023","journal-title":"Am. Heart J. Plus Cardiol. Res. Pract."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5114\/ada.2018.72585","article-title":"Wound Healing Complications in Oncological Patients: Perspectives for Cellular Therapy","volume":"36","author":"Wardowska","year":"2019","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_194","first-page":"49","article-title":"Wound Healing in Older Oncologic Patients. Nowotwory","volume":"71","author":"Kenig","year":"2021","journal-title":"J. Oncol."},{"key":"ref_195","unstructured":"(2024, September 11). Immunotherapy and Organ-Related Inflammation\u2014Side Effects\u2014NCI, Available online: https:\/\/www.cancer.gov\/about-cancer\/treatment\/side-effects\/organ-inflammation."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1158\/2326-6066.CIR-20-0372","article-title":"Understanding and Overcoming the Inflammatory Toxicities of Immunotherapy","volume":"8","author":"Dougan","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"ref_197","doi-asserted-by":"crossref","unstructured":"Zheng, S., Song, Q., and Zhang, P. (2021). Metabolic Modifications, Inflammation, and Cancer Immunotherapy. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.703681"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4240\/wjgs.v15.i2.127","article-title":"Minimum Platelet Count Threshold before Invasive Procedures in Cirrhosis: Evolution of the Guidelines","volume":"15","author":"Biolato","year":"2023","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_199","unstructured":"(2024, September 11). Platelet Transfusion Before Surgery for People with Low Platelet Counts. Available online: https:\/\/www.cochrane.org\/CD012779\/HAEMATOL_platelet-transfusion-surgery-people-low-platelet-counts."},{"key":"ref_200","first-page":"CD012779","article-title":"Prophylactic Platelet Transfusions Prior to Surgery for People with a Low Platelet Count","volume":"2017","author":"Estcourt","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_201","unstructured":"(2024, September 11). Perioperative Blood Management: Strategies to Minimize Transfusions\u2014UpToDate. Available online: https:\/\/www.uptodate.com\/contents\/perioperative-blood-management-strategies-to-minimize-transfusions#H1920440186."},{"key":"ref_202","unstructured":"(2024, September 11). ISBT Platelet Transfusion. Available online: https:\/\/www.isbtweb.org\/resources\/educational-modules-on-clinical-use-of-blood\/platelet-transfusion.html."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cll.2021.07.005","article-title":"Platelet Transfusion","volume":"41","author":"Yuan","year":"2021","journal-title":"Clin. Lab. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2015-07-659656","article-title":"High-Dose Dexamethasone vs Prednisone for Treatment of Adult Immune Thrombocytopenia: A Prospective Multicenter Randomized Trial","volume":"127","author":"Wei","year":"2016","journal-title":"Blood"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1182\/bloodadvances.2017009860","article-title":"Management of Newly Diagnosed Immune Thrombocytopenia: Can We Change Outcomes?","volume":"1","author":"Neunert","year":"2017","journal-title":"Blood Adv."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1182\/bloodadvances.2023010975","article-title":"Prednisone vs High-Dose Dexamethasone in Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Randomized Trial","volume":"8","author":"Mazzucconi","year":"2024","journal-title":"Blood Adv."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"e12592","DOI":"10.1002\/rth2.12592","article-title":"Corticosteroid Overuse in Adults with Immune Thrombocytopenia: Cause for Concern","volume":"5","author":"Cuker","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/aob-20-87","article-title":"Efficacy and Mechanism of Intravenous Immunoglobulin Treatment for Immune Thrombocytopenia in Adults","volume":"6","author":"Almizraq","year":"2021","journal-title":"Ann. Blood"},{"key":"ref_209","first-page":"133","article-title":"Mechanisms of IVIG Action in Immune Thrombocytopenic Purpura","volume":"50","author":"Hansen","year":"2004","journal-title":"Clin. Lab."},{"key":"ref_210","unstructured":"Rassouli, S. (2024, September 11). A Guide to IVIG Treatment for ITP|AmeriPharma\u2122 Specialty. Available online: https:\/\/ameripharmaspecialty.com\/a-guide-to-ivig-treatment-for-itp\/."},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Shen, N., Qiao, J., Jiang, Y., Yan, J., Wu, R., Yin, H., Zhu, S., and Li, J. (2024). Thrombopoietin Receptor Agonists Use and Risk of Thrombotic Events in Patients with Immune Thrombocytopenic Purpura: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Biomed. Rep., 20.","DOI":"10.3892\/br.2024.1732"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1182\/blood.2023020243","article-title":"TPO-RAs and ITP Remission: Cause or Coincidence?","volume":"141","author":"Sanfilippo","year":"2023","journal-title":"Blood"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00277-023-05114-8","article-title":"Use of Thrombopoietin Receptor Agonists in Adults with Immune Thrombocytopenia: A Systematic Review and Central European Expert Consensus","volume":"102","author":"Ionita","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Yassin, M.A., Al-Rasheed, M., Al-Khaboori, M., Marashi, M., Osman, H., Wali, Y., Al Kindi, S., Alsayegh, F., and Provan, D. (2023). Thrombopoietin-Receptor Agonists for Adult Patients with Immune Thrombocytopenia: A Narrative Review and an Approach for Managing Patients Fasting Intermittently. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1260487"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"100647","DOI":"10.1016\/j.blre.2019.100647","article-title":"Tapering and Discontinuation of Thrombopoietin Receptor Agonists in Immune Thrombocytopenia: Real-World Recommendations","volume":"41","author":"Zaja","year":"2020","journal-title":"Blood Rev."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 Guidelines for Immune Thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Scott, M. (2024). Not So BenignImmune Thrombocytopenia: New and Emerging Therapies for a Challenging \u201cBenign\u201d Hematologic Disease. Hematologist, 21.","DOI":"10.1182\/hem.V21.3.202434"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1016\/S2352-3026(20)30253-2","article-title":"Preparing Patients with Immune Thrombocytopenia for Surgery: What Are the Options?","volume":"7","author":"Bussel","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"300060520976477","DOI":"10.1177\/0300060520976477","article-title":"Immunomodulatory Cytokine Interleukin-35 and Immune Thrombocytopaenia","volume":"48","author":"Zhu","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"ref_220","first-page":"1010","article-title":"Prednison Provokes Serum and Vasoactive Substances in a Mice Model of Immune Thrombocytopenia","volume":"19","author":"Zhang","year":"2016","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_221","first-page":"91","article-title":"Regulation of Non-Classical Immune Parameters in Immune Thrombocytopenic Purpura Mice by a Spleen-Invigorating, Qi-Replenishing and Blood-Containing Formula","volume":"2","author":"Li","year":"2015","journal-title":"J. Tradit. Chin. Med. Sci."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1179\/16078454137.0000000104","article-title":"Alternate Considerations for Current Concepts in ITP","volume":"19","author":"Thachil","year":"2014","journal-title":"Hematology"},{"key":"ref_223","unstructured":"Yasir, M., Goyal, A., and Sonthalia, S. (2024). Corticosteroid Adverse Effects. StatPearls, StatPearls Publishing."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2352-3026(16)30109-0","article-title":"High-Dose Dexamethasone Compared with Prednisone for Previously Untreated Primary Immune Thrombocytopenia: A Systematic Review and Meta-Analysis","volume":"3","author":"Mithoowani","year":"2016","journal-title":"Lancet Haematol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1055\/s-0037-1604168","article-title":"Efficacy of Dexamethasone for Acute Primary Immune Thrombocytopenia Compared to Prednisolone: A Systematic Review and Meta-Analysis","volume":"1","author":"Arai","year":"2017","journal-title":"TH Open"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Xiao, Z., and Murakhovskaya, I. (2023). Rituximab Resistance in ITP and Beyond. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1215216"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"368504221102786","DOI":"10.1177\/00368504221102786","article-title":"Eltrombopag Improves Refractory Thrombocytopenia in Patients with Sj\u00f6gren\u2019s Syndrome","volume":"105","author":"Xu","year":"2022","journal-title":"Sci. Prog."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"2195016","DOI":"10.1080\/09537104.2023.2195016","article-title":"Additional Efficacy Analysis of Avatrombopag Phase III Data for the Treatment of Adults with Immune Thrombocytopenia","volume":"34","author":"Jain","year":"2023","journal-title":"Platelets"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1182\/blood-2023-190511","article-title":"Efficacy and Safety of Fostamatinib for Immune Thrombocytopenia in Clinical Practice in Spain: Interim Results of Fostames, Our National Fostamatinib Registry","volume":"142","author":"Domingo","year":"2023","journal-title":"Blood"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s10067-023-06820-4","article-title":"Efficacy and Safety of Mycophenolate Mofetil in Patients with Immune Thrombocytopenic Purpura: A Systematic Review and Meta-Analysis","volume":"43","author":"Abdelwahab","year":"2024","journal-title":"Clin. Rheumatol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ccr3.182","article-title":"Refractory Immune Thrombocytopenia. Successful Treatment with Repeated Cyclosporine A: Two Case Reports","volume":"3","author":"Hlusi","year":"2015","journal-title":"Clin. Case Rep."},{"key":"ref_232","first-page":"217","article-title":"Safety and Efficacy of Azathioprine in Immune Thrombocytopenia","volume":"11","author":"Mishra","year":"2021","journal-title":"Am. J. Blood Res."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjmed.2003.12.024","article-title":"Danazol Therapy in Patients with Chronic Idiopathic Thrombocytopenic Purpura: Long-Term Results","volume":"116","author":"Maloisel","year":"2004","journal-title":"Am. J. Med."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2015-03-632000","article-title":"How Does Dapsone Work in Immune Thrombocytopenia? Implications for Dosing","volume":"125","author":"Hill","year":"2015","journal-title":"Blood"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"103826","DOI":"10.1016\/j.critrevonc.2022.103826","article-title":"Corticosteroids in Oncology: Use, Overuse, Indications, Contraindications. An Italian Association of Medical Oncology (AIOM)\/Italian Association of Medical Diabetologists (AMD)\/Italian Society of Endocrinology (SIE)\/Italian Society of Pharmacology (SIF) Multidisciplinary Consensus Position Paper","volume":"180","author":"Faggiano","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejca.2020.09.032","article-title":"How to Manage Patients with Corticosteroids in Oncology in the Era of Immunotherapy?","volume":"141","author":"Aldea","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_237","unstructured":"(2024, October 11). Steroids (Dexamethasone, Prednisolone, Methylprednisolone and Hydrocortisone). Available online: https:\/\/www.cancerresearchuk.org\/about-cancer\/treatment\/drugs\/steroids."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"e1624","DOI":"10.1002\/cnr2.1624","article-title":"Mycophenolate Mofetil for Immune Checkpoint Inhibitor-Related Hepatotoxicity Relapsing during Dose Reduction of Corticosteroid: A Report of Two Cases and Literature Review","volume":"5","author":"Ueno","year":"2022","journal-title":"Cancer Rep."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1365-2249.2003.02290.x","article-title":"The Immunosuppressive Drug Mycophenolate Mofetil Impairs the Adhesion Capacity of Gastrointestinal Tumour Cells","volume":"134","author":"Leckel","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/jgh3.12868","article-title":"Efficacy and Safety of Mycophenolate Mofetil in Treating Immune-related Hepatitis Induced by Immune Checkpoint Inhibitor Use: A Retrospective Study","volume":"7","author":"Kadokawa","year":"2023","journal-title":"JGH Open"},{"key":"ref_241","first-page":"421","article-title":"Cyclosporin-A Associated Malignancy","volume":"1","author":"Durnian","year":"2007","journal-title":"Clin. Ophthalmol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0896-8411(89)80010-1","article-title":"The Risk of Neoplasms in Patients Treated with Cyclosporine A","volume":"2","author":"Cockburn","year":"1989","journal-title":"J. Autoimmun."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/17401","article-title":"Cyclosporine Induces Cancer Progression by a Cell-Autonomous Mechanism","volume":"397","author":"Hojo","year":"1999","journal-title":"Nature"},{"key":"ref_244","unstructured":"Mohammadi, O., and Kassim, T.A. (2023). Azathioprine. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/aje\/kws375","article-title":"Use of Azathioprine and the Risk of Cancer in Inflammatory Bowel Disease","volume":"177","author":"Pasternak","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"ref_246","unstructured":"Ashfaq, S., Pellegrini, M.V., and Can, A.S. (2024). Danazol. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_247","unstructured":"(2024, October 11). Danazol: Uses, Dosage, Side Effects. Available online: https:\/\/www.drugs.com\/danazol.html."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"e12968","DOI":"10.1111\/tid.12968","article-title":"Dapsone Safety in Hematology Patients: Pathways to Optimizing Pneumocystis Jirovecii Pneumonia Prophylaxis in Hematology Malignancy and Transplant Recipients","volume":"20","author":"Urbancic","year":"2018","journal-title":"Transpl. Infect. Dis."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1177\/0310057X1003800618","article-title":"Dapsone-Associated Methaemoglobinaemia in Patients with a Haematologic Malignancy","volume":"38","author":"Subramaniam","year":"2010","journal-title":"Anaesth. Intensive Care"},{"key":"ref_250","unstructured":"Hanif, N., and Anwer, F. (2024). Rituximab. StatPearls, StatPearls Publishing."},{"key":"ref_251","unstructured":"(2024, October 11). Rituximab: Principles of Use and Adverse Effects in Rheumatologic Disease\u2014UpToDate. Available online: https:\/\/www.uptodate.com\/contents\/rituximab-principles-of-use-and-adverse-effects-in-rheumatologic-disease."},{"key":"ref_252","unstructured":"(2024, October 11). Rituximab. Available online: https:\/\/go.drugbank.com\/drugs\/DB00073."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/22\/6738\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:29:05Z","timestamp":1760113745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/22\/6738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":252,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["jcm13226738"],"URL":"https:\/\/doi.org\/10.3390\/jcm13226738","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]}}}